Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Light therapy targets skin cancer lesions

NCT ID NCT05872854

Summary

This study tested a new treatment for early-stage mycosis fungoides, a type of skin lymphoma. Ten patients applied a special ointment to their skin lesions, which was then activated by visible light twice a week for up to a year. The goal was to see if this light-activated treatment could reduce the size and severity of the skin lesions and improve symptoms like itching.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS T CELL LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Perelman Center for Advanced Medicine

    Philadelphia, Pennsylvania, 19034, United States

Conditions

Explore the condition pages connected to this study.